| Molecular characterization of cancers with NTRK gene fusions Z Gatalica, J Xiu, J Swensen, S Vranic Modern Pathology 32 (1), 147-153, 2019 | 489 | 2019 |
| Prevalence of homologous recombination–related gene mutations across multiple cancer types AL Heeke, MJ Pishvaian, F Lynce, J Xiu, JR Brody, WJ Chen, TM Baker, ... JCO precision oncology 2, 1-13, 2018 | 398 | 2018 |
| Mutational burden, immune checkpoint expression, and mismatch repair in glioma: implications for immune checkpoint immunotherapy TR Hodges, M Ott, J Xiu, Z Gatalica, J Swensen, S Zhou, JT Huse, ... Neuro-oncology 19 (8), 1047-1057, 2017 | 391 | 2017 |
| Landscape of tumor mutation load, mismatch repair deficiency, and PD-L1 expression in a large patient cohort of gastrointestinal cancers ME Salem, A Puccini, A Grothey, D Raghavan, RM Goldberg, J Xiu, ... Molecular Cancer Research 16 (5), 805-812, 2018 | 228 | 2018 |
| Comparative molecular analyses of left-sided colon, right-sided colon, and rectal cancers ME Salem, BA Weinberg, J Xiu, WS El-Deiry, JJ Hwang, Z Gatalica, ... Oncotarget 8 (49), 86356, 2017 | 204 | 2017 |
| High microsatellite instability (MSI-H) colorectal carcinoma: a brief review of predictive biomarkers in the era of personalized medicine Z Gatalica, S Vranic, J Xiu, J Swensen, S Reddy Familial cancer 15 (3), 405-412, 2016 | 191 | 2016 |
| Comparative molecular analyses of esophageal squamous cell carcinoma, esophageal adenocarcinoma, and gastric adenocarcinoma ME Salem, A Puccini, J Xiu, D Raghavan, HJ Lenz, WM Korn, AF Shields, ... The oncologist 23 (11), 1319-1327, 2018 | 172 | 2018 |
| Molecular profiling of biliary cancers reveals distinct molecular alterations and potential therapeutic targets BA Weinberg, J Xiu, MR Lindberg, AF Shields, JJ Hwang, K Poorman, ... Journal of Gastrointestinal Oncology 10 (4), 652, 2019 | 153 | 2019 |
| Immune checkpoint blockade as a potential therapeutic target: surveying CNS malignancies ST Garber, Y Hashimoto, SP Weathers, J Xiu, Z Gatalica, RGW Verhaak, ... Neuro-oncology 18 (10), 1357-1366, 2016 | 143 | 2016 |
| Relationship between MLH1, PMS2, MSH2 and MSH6 gene‐specific alterations and tumor mutational burden in 1057 microsatellite instability‐high solid tumors ME Salem, JN Bodor, A Puccini, J Xiu, RM Goldberg, A Grothey, WM Korn, ... International journal of cancer 147 (10), 2948-2956, 2020 | 137 | 2020 |
| Characterization of KRAS mutation subtypes in non–small cell lung cancer J Judd, N Abdel Karim, H Khan, AR Naqash, Y Baca, J Xiu, ... Molecular cancer therapeutics 20 (12), 2577-2584, 2021 | 125 | 2021 |
| Molecular Characterization of KRAS Wild-type Tumors in Patients with Pancreatic Adenocarcinoma PA Philip, I Azar, J Xiu, MJ Hall, AE Hendifar, E Lou, JJ Hwang, J Gong, ... Clinical Cancer Research 28 (12), 2704-2714, 2022 | 121 | 2022 |
| Molecular profiling of 6,892 colorectal cancer samples suggests different possible treatment options specific to metastatic sites WS El-Deiry, N Vijayvergia, J Xiu, A Scicchitano, B Lim, NS Yee, ... Cancer biology & therapy 16 (12), 1726-1737, 2015 | 105 | 2015 |
| Comprehensive analysis of cancers of unknown primary for the biomarkers of response to immune checkpoint blockade therapy Z Gatalica, J Xiu, J Swensen, S Vranic European journal of cancer 94, 179-186, 2018 | 104 | 2018 |
| Targetable gene fusions associate with the IDH wild-type astrocytic lineage in adult gliomas SD Ferguson, S Zhou, JT Huse, JF de Groot, J Xiu, DS Subramaniam, ... Journal of Neuropathology & Experimental Neurology 77 (6), 437-442, 2018 | 97 | 2018 |
| NUTM1-rearranged neoplasia: a multi-institution experience yields novel fusion partners and expands the histologic spectrum TM Stevens, D Morlote, J Xiu, J Swensen, M Brandwein-Weber, ... Modern Pathology 32 (6), 764-773, 2019 | 94 | 2019 |
| Molecular profiling of appendiceal adenocarcinoma and comparison with right-sided and left-sided colorectal cancer R Tokunaga, J Xiu, C Johnston, RM Goldberg, PA Philip, A Seeber, ... Clinical Cancer Research 25 (10), 3096-3103, 2019 | 87 | 2019 |
| Comprehensive genomic profiling of gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs) A Puccini, K Poorman, ME Salem, D Soldato, A Seeber, RM Goldberg, ... Clinical Cancer Research 26 (22), 5943-5951, 2020 | 85 | 2020 |
| Molecular profile of BRCA-mutated biliary tract cancers G Spizzo, A Puccini, J Xiu, RM Goldberg, A Grothey, AF Shields, SP Arora, ... Esmo Open 5 (3), e000682, 2020 | 82 | 2020 |
| Potential novel therapy targets in neuroendocrine carcinomas of the breast S Vranic, J Palazzo, S Sanati, E Florento, E Contreras, J Xiu, J Swensen, ... Clinical breast cancer 19 (2), 131-136, 2019 | 67 | 2019 |
